Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

[A Case of Good Quality of Life(QOL)and Favorable Response to Transarterial Chemoembolization(TACE)against Synchronous Multiple Liver Metastases].

Sugimoto K, Sakamoto K, Amemiya K, Tsuchiya Y, Hagiwara T, Matsuzawa H, Makino Y, Motegi S, Kawai M, Ishiyama S, Kamiyama H, Takahashi M, Kojima Y, Tomiki Y, Kuwatsuru R.

Gan To Kagaku Ryoho. 2019 Apr;46(4):730-732. Japanese.

PMID:
31164517
2.

The power of genes: a case of unusually severe systemic toxicity after localized hepatic chemoembolization with irinotecan-eluted microspheres for metastatic colon cancer.

Cruz JE, Saksena R, Jabbour SK, Nosher JL, Hermes-DeSantis E, Moss RA.

Ann Pharmacother. 2014 Dec;48(12):1646-50. doi: 10.1177/1060028014550646. Epub 2014 Sep 8.

PMID:
25202035
3.

How can we treat a patient with liver cirrhosis (hepatitis C virus), hepatocellular carcinoma, and synchronous colon cancer?

Antoniou E, Mantas D, Paraskeva P, Dimitroulis D, Smyrnis A, Nikitakis N, Labadariou A, Tsavaris N, Vernicos P, Kostakis A.

Transplant Proc. 2012 Nov;44(9):2745-7. doi: 10.1016/j.transproceed.2012.09.003.

PMID:
23146511
4.

Response to Modified TEGAFIRI in a Patient with Synchronous Multiple Liver Metastases of Colon Cancer.

Takanori G, Youhei K, Katsuji S, Mitsuhiro M, Kanji K, Akio Y.

Case Rep Gastroenterol. 2011 Jan;5(1):95-9. doi: 10.1159/000324399. Epub 2011 Feb 5.

5.

Transarterial chemoembolization with miriplatin-lipiodol emulsion for neuroendocrine metastases of the liver.

Iwazawa J, Ohue S, Yasumasa K, Mitani T.

World J Radiol. 2010 Dec 28;2(12):468-71. doi: 10.4329/wjr.v2.i12.468.

6.

Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: long-term results over a 10-year period.

Gruber-Rouh T, Naguib NN, Eichler K, Ackermann H, Zangos S, Trojan J, Beeres M, Harth M, Schulz B, Nour-Eldin A NE, Vogl TJ.

Int J Cancer. 2014 Mar 1;134(5):1225-31. doi: 10.1002/ijc.28443. Epub 2013 Sep 3.

7.

Transarterial chemoembolization (TACE) for colorectal liver metastases--current status and critical review.

Massmann A, Rodt T, Marquardt S, Seidel R, Thomas K, Wacker F, Richter GM, Kauczor HU, Bücker A, Pereira PL, Sommer CM.

Langenbecks Arch Surg. 2015 Aug;400(6):641-59. doi: 10.1007/s00423-015-1308-9. Epub 2015 Jun 19. Review.

PMID:
26088872
8.
9.

Liver transplantation in a patient with unresectable colorectal liver metastases -- a case report.

Hrehoreţ D, Alexandrescu S, Braşoveanu V, Grigorie R, Zielinski C, Popescu I.

Chirurgia (Bucur). 2013 Sep-Oct;108(5):719-24.

10.

Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors.

Fiore F, Del Prete M, Franco R, Marotta V, Ramundo V, Marciello F, Di Sarno A, Carratù AC, de Luca di Roseto C, Colao A, Faggiano A.

Endocrine. 2014 Sep;47(1):177-82. doi: 10.1007/s12020-013-0130-9. Epub 2014 Jan 3.

PMID:
24385266
11.

Chemoembolization Adopting Polyethylene Glycol Drug-Eluting Embolics Loaded With Doxorubicin for the Treatment of Hepatocellular Carcinoma.

Aliberti C, Carandina R, Sarti D, Mulazzani L, Pizzirani E, Guadagni S, Fiorentini G.

AJR Am J Roentgenol. 2017 Aug;209(2):430-434. doi: 10.2214/AJR.16.17477. Epub 2017 May 24.

PMID:
28537756
12.

Rupture of Hepatocellular Carcinoma after Transarterial Chemoembolization followed by Massive Gastric Bleeding.

Nishida K, Lefor AK, Funabiki T.

Case Reports Hepatol. 2018 Jun 4;2018:4576276. doi: 10.1155/2018/4576276. eCollection 2018.

13.

Liver metastases: neoadjuvant downsizing with transarterial chemoembolization before laser-induced thermotherapy.

Vogl TJ, Mack MG, Balzer JO, Engelmann K, Straub R, Eichler K, Woitaschek D, Zangos S.

Radiology. 2003 Nov;229(2):457-64. Epub 2003 Sep 18.

PMID:
14500854
14.

[Two Cases of Effective Hepatic Arterial Infusion Chemotherapy for Liver Metastases of Colon Cancer Resistant to Systemic Chemotherapy].

Date Y, Hisaka T, Takahashi K, Nakayama G, Akashi M, Kawahara R, Sakai H, Ishikawa H, Yasunaga M, Uchida S, Horiuchi H, Okuda K, Matsunaga M, Miwa K, Akagi Y.

Gan To Kagaku Ryoho. 2015 Nov;42(12):1518-20. Japanese.

PMID:
26805082
15.

Neoadjuvant TACE before laser induced thermotherapy (LITT) in the treatment of non-colorectal non-breast cancer liver metastases: feasibility and survival rates.

Vogl TJ, Kreutzträger M, Gruber-Rouh T, Eichler K, Nour-Eldin NE, Zangos S, Naguib NN.

Eur J Radiol. 2014 Oct;83(10):1804-10. doi: 10.1016/j.ejrad.2014.06.029. Epub 2014 Jul 7.

PMID:
25082479
16.

[Multiple liver metastases due to sigmoid colon cancer successfully treated by degradable starch microspheres (DSM)-TAE, radiofrequency ablation therapy, and Uzel/UFT].

Ishikawa T, Higuchi K, Kubota T, Seki K, Ohta H, Yoshida T, Kamimura T.

Gan To Kagaku Ryoho. 2010 Feb;37(2):335-8. Japanese.

PMID:
20154497
17.

Non-functioning pancreatic neuroendocrine tumor accompanied with multiple liver metastases: remorseful case and literature review.

Hori T, Takaori K, Kawaguchi M, Ogawa K, Masui T, Ishii T, Nagata H, Narita M, Kodama Y, Uza N, Uemoto S.

JOP. 2014 Nov 28;15(6):622-5. doi: 10.6092/1590-8577/2861.

18.

Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results.

de Baere T, Deschamps F, Teriitheau C, Rao P, Conengrapht K, Schlumberger M, Leboulleux S, Baudin E, Hechellhammer L.

J Vasc Interv Radiol. 2008 Jun;19(6):855-61. doi: 10.1016/j.jvir.2008.01.030. Epub 2008 Mar 19.

PMID:
18503899
19.

Sustained multiple organ ischaemia after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma.

Kim YW, Kwon JH, Nam SW, Jang JW, Jung HS, Shin YR, Park ES, Shim DJ.

Exp Ther Med. 2018 Feb;15(2):1479-1483. doi: 10.3892/etm.2017.5540. Epub 2017 Nov 22.

20.

Complete pathological response of unresectable liver metastases from colorectal cancer after trans-arterial chemoembolization with drug-eluting beads loaded with irinotecan (DEBIRI) and concomitant systemic FOLFOX: A case report from the FFCD 1201 trial.

Pernot S, Artru P, Mithieux F, Marsot J, Watkin E, Pellerin O, Lledo G, Chalabreysse P, Desramé J, Taieb J.

Clin Res Hepatol Gastroenterol. 2015 Dec;39(6):e73-7. doi: 10.1016/j.clinre.2015.06.004. Epub 2015 Jul 2.

PMID:
26141343

Supplemental Content

Support Center